Tamara Madacsy
Szeged, CS 6720, Hungary
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 22 publications
Beyond the mutations: spatiotemporal regulation of CFTR by cAMP and calcium signaling in epithelial physiology and cystic fibrosis.
Journal: Cellular & molecular biology letters
Published: May 30, 2025
Ca2+ signaling of pancreatic acinar cells in malignant hyperthermia susceptibility.
Journal: Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.]
Published: August 23, 2024
Reduction of intracellular oxidative stress with a copper-incorporated layered double hydroxide.
Journal: Chemical communications (Cambridge, England)
Published: January 10, 2024
Heavy metals in cigarette smoke strongly inhibit pancreatic ductal function and promote development of chronic pancreatitis.
Journal: Clinical and translational medicine
Published: December 07, 2023
Orai1 calcium channel inhibition prevents progression of chronic pancreatitis.
Journal: JCI insight
Published: December 05, 2022
Human pancreatic ductal organoids with controlled polarity provide a novel ex vivo tool to study epithelial cell physiology.
Journal: Cellular and molecular life sciences : CMLS
Published: July 11, 2022
Confinement of Triple-Enzyme-Involved Antioxidant Cascade in Two-Dimensional Nanostructure.
Journal: ACS materials letters
Published: July 01, 2022
Impaired regulation of PMCA activity by defective CFTR expression promotes epithelial cell damage in alcoholic pancreatitis and hepatitis.
Journal: Cellular and molecular life sciences : CMLS
Published: January 05, 2022
Bile acid- and ethanol-mediated activation of Orai1 damages pancreatic ductal secretion in acute pancreatitis.
Journal: The Journal of physiology
Published: August 02, 2021
Kynurenic Acid and Its Analogue SZR-72 Ameliorate the Severity of Experimental Acute Necrotizing Pancreatitis.
Journal: Frontiers in immunology
Published: April 29, 2021
Advances in the optimization of therapeutic drug monitoring using serum, tissue and faecal anti-tumour necrosis factor concentration in patients with inflammatory bowel disease treated with TNF-α antagonists.
Journal: Expert opinion on biological therapy
Published: February 15, 2021
Last Updated: 09/26/2026